MedTrace Logo

Assessment of the Bioavailability of Iron in Iron Fortified Bouillon Cubes in Healthy Nigerian Women

NCT02815449 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2017-08-01

No results posted yet for this study

Summary

The prevalence of iron deficiency anemia is a wide spread problem in Africa and iron fortification can be an effective strategy to decrease this.

In the current study adding different levels of a stabilizer to iron fortified cubes and it's effect on iron bioavailability from these cubes will be studied in the context of a Nigerian meal in women.

24 Female subjects with low serum ferritin levels will be included in the study. The study will last 64 days and subjects will be asked to consume a breakfast and lunch prepared with a bouillon cube with isotope labeled iron during 3 periods of 5 consecutive days. The absorption of iron will be evaluated after every period and compared between the cubes.

Conditions

Interventions

OTHER

Meals prepared with iron fortified cube with Low stabilizer level

Meals prepared with iron fortified cube with Low stabilizer level

OTHER

Meals prepared with iron fortified cube with Medium stabilizer level

Meals prepared with iron fortified cube with Medium stabilizer level

OTHER

Meals prepared with iron fortified cube with High stabilizer level

Meals prepared with iron fortified cube with High stabilizer level

Sponsors & Collaborators

  • Obafemi Awolowo University

    collaborator OTHER

  • Unilever R&D

    lead INDUSTRY

Principal Investigators

  • Funke Olumakaiye, PhD · Obafemi Awolowo University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-08
Primary Completion
2017-07-24
Completion
2017-07-24

Countries

  • Nigeria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02815449 on ClinicalTrials.gov